Literature DB >> 17903675

Acute dyskinesia on starting methylphenidate after risperidone withdrawal.

Chris P Hollis1, Anne Thompson.   

Abstract

We report on acute and transient dyskinesia occurring within hours of taking modified-release methylphenidate (Concerta XL) in a stimulant-naïve 7-year-old boy who had recently stopped taking risperidone. We propose that the mechanism of this adverse drug reaction is likely to be an interaction between supersensitive dopamine receptors and acute exposure to an indirect dopamine agonist. Clinicians need to be aware of this potential side effect, and to use the combination of psychostimulants and neuroleptic drugs with caution.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17903675     DOI: 10.1016/j.pediatrneurol.2007.05.017

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  8 in total

1.  The dopamine dilemma: using stimulants and antipsychotics concurrently.

Authors:  Jason Yanofski
Journal:  Psychiatry (Edgmont)       Date:  2010-06

2.  Onset of abnormal movements and cardiovascular symptoms after acute change in complex polypharmacy in a child with attention-deficit/hyperactivity disorder and mood symptoms.

Authors:  Presenters Ornella Potter; Nadyah John; Discussant Barbara J Coffey
Journal:  J Child Adolesc Psychopharmacol       Date:  2012-10       Impact factor: 2.576

3.  The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective.

Authors:  Anton Pottegård; Bine Kjøller Bjerregaard; Dorte Glintborg; Lisbeth Sandal Kortegaard; Jesper Hallas; Søren Ilsøe Moreno
Journal:  Eur J Clin Pharmacol       Date:  2012-07-19       Impact factor: 2.953

4.  Movement disorders and use of risperidone and methylphenidate: a review of case reports and an analysis of the WHO database in pharmacovigilance.

Authors:  Dominik Stämpfli; Stefan Weiler; Andrea M Burden
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-07-03       Impact factor: 4.785

5.  Acute Hyperkinetic Movement Disorders as a Multifactorial Pharmacodynamic Drug Interaction Between Methylphenidate and Risperidone in Children and Adolescents.

Authors:  Mohamed Mohamoud; Qi Chen; David Croteau; Carmen Cheng; Keith Burkhart; Donna A Volpe; Cindy Kortepeter; Dorothy Demczar; Marc Stone
Journal:  J Clin Psychopharmacol       Date:  2022 May-Jun 01       Impact factor: 3.118

6.  Worsening Choreoathetosis in Huntington's Disease with Fluoxetine, Lisdexamfetamine, and Melatonin: A Case Report.

Authors:  Clayton J Hamilton; Tysen K Timmer; Robert C Munjal; Fernando Cardozo-Pelaez; Ian R Mcgrane
Journal:  Innov Clin Neurosci       Date:  2018-08-01

Review 7.  Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.

Authors:  Ole Jakob Storebø; Nadia Pedersen; Erica Ramstad; Maja Lærke Kielsholm; Signe Sofie Nielsen; Helle B Krogh; Carlos R Moreira-Maia; Frederik L Magnusson; Mathilde Holmskov; Trine Gerner; Maria Skoog; Susanne Rosendal; Camilla Groth; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Sasja J Håkonsen; Lise Aagaard; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2018-05-09

8.  Dystonia with MPH/Risperidone Combined Therapy for ADHD.

Authors:  J Gordon Millichap; Michelle M Yee
Journal:  Pediatr Neurol Briefs       Date:  2016-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.